Prognostic effect and modulation of cardiac sympathetic function in heart failure patients treated with cardiac resynchronization therapy

被引:10
|
作者
Moreira, Rita Ilhao [1 ]
Abreu, Ana [1 ]
Portugal, Guilherme [1 ]
Oliveira, Luis [2 ]
Oliveira, Mario [1 ]
Rodrigues, Ines [1 ]
Cruz, Madalena Coutinho [1 ]
Cunha, Pedro Silva [1 ]
Santos, Vanessa [3 ]
Clara, Helena Santa [3 ]
Carmo, Miguel Mota [1 ,4 ]
Ferreira, Rui Cruz [1 ]
机构
[1] Hosp Santa Marta, Centro Hospitalar Lisboa Cent, Dept Cardiol, Rua Santa Marta, . 50, P-1169-024 Lisbon, Portugal
[2] Nucl Med Dept, Diag Clin Quadrantes, Med, Lisbon, Portugal
[3] Univ Lisbon, Human Kinet Fac, CIPER, Lisbon, Portugal
[4] Univ Nova Lisboa, NOVA Med Sch, Lisbon, Portugal
关键词
Heart failure; cardiac innervation; diagnostic and prognostic application; METAIODOBENZYLGUANIDINE UPTAKE; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; NERVOUS ACTIVITY; ECHOCARDIOGRAPHY; RECOMMENDATIONS; DISINTEGRITY; IMPROVEMENT; PARAMETERS; OUTFLOW;
D O I
10.1007/s12350-018-1357-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Cardiac autonomic dysfunction as assessed by I-123-metaiodobenzylguanidine (I-123-mIBG) scintigraphy is associated with poor prognosis in heart failure (HF) patients. Although cardiac resynchronization therapy (CRT) has emerged as an effective therapy in improving outcomes on HF patients, its effect on cardiac sympathetic nervous function is still not fully understood. We aimed to study the value of pre-implantation I-123-mIBG late heart-to-mediastinum ratio (HMR) as a predictor of response and outcomes after CRT and to correlate modification in this parameter with CRT response and functional improvement. Methods and Results BETTER-HF (Benefit of exercise training therapy and cardiac resynchronization in HF patients) is a prospective randomized clinical trial including HF patients submitted CRT (mean LVEF 24 +/- 8%, 74% NYHA class >= III) who underwent a clinical, echocardiographic, and scintigraphic assessment before and 6 months after CRT. One-hundred and twenty-one patients were included. Echocardiographic response was observed in 54% and composite outcome of cardiac mortality, cardiac transplant or heart failure hospitalization in 24% of patients. Baseline late HMR was an independent predictor of CRT response (regression coefficient 2.906, 95% CI 0.293-3.903, P .029) and outcomes (HR 0.066 95% CI 0.005-0.880, P .040). At follow-up, I-123-mIBG imaging showed positive changes in cardiac sympathetic nerve activity only in responders to CRT (1.36 +/- 0.14 prior vs. 1.42 +/- 0.16 after CRT, P .039). There was a significant correlation between improvement in late HMR and improvement in peak oxygen consumption (r 0.547, P < .001). Conclusion In our study, baseline cardiac denervation predicted response and clinical outcomes after CRT implantation. Cardiac sympathetic function was improved only in patients who responded to CRT and these positive changes were correlated with improvement in functional capacity.
引用
收藏
页码:283 / 290
页数:8
相关论文
共 50 条
  • [21] Functional Class IV Heart Failure Patients Treated with Cardiac Resynchronization Therapy
    Castel, M. A.
    Mont, L.
    Perez-Villa, F.
    Tolosana, J.
    Sitges, M.
    Roig, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S101 - S101
  • [22] Chemokines profile in patients with chronic heart failure treated with cardiac resynchronization therapy
    Ptaszynska-Kopczynska, Katarzyna
    Sawicka, Emilia
    Marcinkiewicz-Siemion, Marta
    Tarasiuk, Ewa
    Lisowska, Anna
    Szpakowicz, Anna
    Witkowski, Marcin
    Kaminski, Marcin
    Charkiewicz, Karol
    Laudanski, Piotr
    Charkiewicz, Miroslaw
    Musial, Wlodzimierz J.
    Kaminski, Karol A.
    ADVANCES IN MEDICAL SCIENCES, 2020, 65 (01): : 102 - 110
  • [23] Prognostic value of cardiac scintigraphy in the prediction of responders to cardiac resynchronization therapy in patients with chronic heart failure
    Atabekov, T.
    Mishkina, A.
    Batalov, R.
    Sazonova, S.
    Krivolapov, S.
    Saushkin, V.
    Khlynin, M.
    Varlamova, Y.
    Zavadovsky, K.
    Popov, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S338 - S338
  • [24] Increase in paced heart rate reduces muscle sympathetic nerve activity in heart failure patients treated with cardiac resynchronization therapy
    Stahlberg, Marcus
    Sander, Mikael
    Mortensen, Lars
    Linde, Cecilia
    Braunschweig, Frieder
    EUROPACE, 2015, 17 (03): : 439 - 446
  • [25] Cardiac resynchronization therapy in heart failure patients: An update
    Jeevanantham, Vinodh
    Daubert, James P.
    Zareba, Woiciech
    CARDIOLOGY JOURNAL, 2009, 16 (03) : 197 - 209
  • [26] Benefit of Cardiac Resynchronization Therapy in Patients with Heart Failure
    Calborean, Veronica
    Ciobanu, Daniela
    Mirea, Sorin Cecil
    Galceava, Oana
    Gheorman, Victor
    Padureanu, Vlad
    Fortofoiu, Catalin Mircea
    Fortofoiu, Maria
    Mita, Adrian
    Dinescip, Sorin Nicolae
    Miscocl, Silvia Alina
    Dinescu, Venera Cristina
    REVISTA DE CHIMIE, 2018, 69 (09): : 2461 - 2464
  • [27] Heart failure patients selection for cardiac resynchronization therapy
    Geng, Junchao
    Wu, Bifeng
    Zheng, Liangrong
    Zhu, Jianhua
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2011, 22 (01) : 32 - 38
  • [28] Evaluation of the effect of cardiac resynchronization therapy on left ventricular function in patients with chronic heart failure
    Gomaa, M. A. R. I. A. M. Mohamed Fathy Mohamed Abdalhakim
    Nawar, M.
    Elsharkawy, E.
    Loutfy, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 86 - 86
  • [29] Perspectives of cardiac resynchronization therapy in patients with heart failure
    Rabinovich, Rafael
    INSUFICIENCIA CARDIACA, 2008, 3 (02) : 100 - 101
  • [30] Effects of cardiac resynchronization therapy in heart failure patients
    Cattadori, Gaia
    Vignati, Carlo
    Bonomi, Alice
    Mapelli, Massimo
    Sciomer, Susanna
    Pepi, Mauro
    Tondo, Claudio
    Ambrosio, Giuseppe
    Di Marco, Silvia
    Baravelli, Massimo
    Agostoni, Piergiuseppe
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0J) : J144 - J145